Non-Current Assets
Other Non-Current Assets
Vertex Pharmaceuticals Other Non-Current Assets increased by 12.6% to $1.24B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 23.7%, from $999.30M to $1.24B. Over 5 years (FY 2020 to FY 2025), Other Non-Current Assets shows an upward trend with a 90.4% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryOther
SignalContext dependent
VolatilityStable
First reportedQ3 2015
Last reportedQ4 2025
How to read this metric
Large fluctuations may relate to changes in long-term investment strategy or tax accounting adjustments.
Detailed definition
A catch-all category for long-term assets that do not fit into major classifications like PPE or Intangibles. This may i...
Peer comparison
Often contains strategic minority investments in technology partners or long-term tax-related items.
Metric ID:
other_non_current_assetsHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $71.10M | $75.52M | $110.80M | $110.70M | $127.30M | $132.50M | $521.80M | $427.50M | $442.70M | $475.20M | $895.30M | $875.70M | $915.60M | $990.20M | $999.30M | $1.01B | $1.08B | $1.10B | $1.24B |
| QoQ Change | — | +6.2% | +46.7% | -0.1% | +15.0% | +4.1% | +293.8% | -18.1% | +3.6% | +7.3% | +88.4% | -2.2% | +4.6% | +8.1% | +0.9% | +0.8% | +7.1% | +1.8% | +12.6% |
| YoY Change | — | — | — | — | +79.0% | +75.5% | +370.9% | +286.2% | +247.8% | +258.6% | +71.6% | +104.8% | +106.8% | +108.4% | +11.6% | +15.0% | +17.8% | +10.9% | +23.7% |
Range$71.10M – $1.24B
CAGR+88.6%
Avg YoY Growth+119.2%
Median YoY Growth+79.0%
Current Streak7 quarters growth
Other Non-Current Assets at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's other non-current assets?
- Vertex Pharmaceuticals (VRTX) reported other non-current assets of $1.24B in Q4 2025.
- How has Vertex Pharmaceuticals's other non-current assets changed year-over-year?
- Vertex Pharmaceuticals's other non-current assets increased by 23.7% year-over-year, from $999.30M to $1.24B.
- What is the long-term trend for Vertex Pharmaceuticals's other non-current assets?
- Over 5 years (2020 to 2025), Vertex Pharmaceuticals's other non-current assets has grown at a 90.4% compound annual growth rate (CAGR), from $49.39M to $1.24B.
- What does other non-current assets mean?
- Miscellaneous long-term investments and assets that the company plans to hold for more than a year.